|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 18 of 28 found articles
| Title: |
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study |
| Author: |
Choueiri, Toni K Eto, Masatoshi Motzer, Robert De Giorgi, Ugo Buchler, Tomas Basappa, Naveen S Méndez-Vidal, María José Tjulandin, Sergei Hoon Park, Se Melichar, Bohuslav Hutson, Thomas Alemany, Carlos McGregor, Bradley Powles, Thomas Grünwald, Viktor Alekseev, Boris Rha, Sun Young Kopyltsov, Evgeny Kapoor, Anil Alonso Gordoa, Teresa Goh, Jeffrey C Staehler, Michael Merchan, Jaime R Xie, Ran Perini, Rodolfo F Mody, Kalgi McKenzie, Jodi Porta, Camillo G |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 24 () nr. 3 pages 228-238 |
| Year: |
2023 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 18 of 28 found articles
| << previous | next >> |